Dr. Jaume Sastre Garriga Receives the 2025 Multiple Sclerosis Award from the Spanish Society of Neurology

Dr. Jaume Sastre Garriga, member of the Neurology Department at Vall d’Hebron University Hospital, principal investigator of the Clinical Neuroimmunology group at the Vall d’Hebron Research Institute (VHIR), and member of the Multiple Sclerosis Centre of Catalonia (Cemcat), has received the 2025 Multiple Sclerosis Award in the scientific category granted by the Spanish Society of Neurology (SEN). The recognition was presented during the SEN 2026 Institutional Ceremony, held at the Palacio Carmen de los Mártires in Granada.

The SEN Awards annually recognize professionals, institutions, and initiatives that have made significant contributions to the advancement of neurology, both from a scientific and social perspective. In the case of the 2025 Multiple Sclerosis Award, Dr. Sastre Garriga’s nomination was submitted by Dr. Ana Belén Caminero Rodríguez, coordinator of the SEN Study Group on Multiple Sclerosis and Related Immunological Diseases.

Dr. Sastre Garriga has carried out his clinical and research activity at Cemcat and VHIR since 2007. He trained as a neurologist at Vall d’Hebron University Hospital and conducted his doctoral research at the Institute of Neurology in London. Between 2002 and 2004, he worked as a clinical researcher in the magnetic resonance imaging and neurorehabilitation units of this institution under the supervision of Professor Alan J. Thompson.

His research career has focused particularly on neuroimaging techniques applied to multiple sclerosis, including functional magnetic resonance imaging and volumetry, as well as neurorehabilitation and progressive forms of the disease. He currently maintains a prominent international scientific activity linked to the study of imaging biomarkers and multiple sclerosis progression.

In addition to his clinical and research work, Dr. Sastre Garriga holds several international scientific positions. He is co-chair of the Steering Committee of Magnetic Resonance Imaging in MS (MAGNIMS), Editor-in-Chief of the journal Multiple Sclerosis Journal, and served for ten years as scientific director of Revista de Neurología (the leading neurology journal in Spain). He was also a member of the executive committee of Rehabilitation in Multiple Sclerosis (RIMS) between 2014 and 2020 and, since 2024, has been a member of the Executive Board of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

‘This recognition is also an award for the collective work of all the professionals who work every day to improve the lives of people with multiple sclerosis. Research only makes sense if it succeeds in translating into a real benefit for patients,’ highlights Dr. Jaume Sastre Garriga.

Multiple sclerosis is a chronic autoimmune neurological disease that affects the central nervous system and has a major impact on patients’ quality of life. Despite the advances achieved over recent decades, significant challenges still remain regarding the progression of disability, the early identification of patients with a poorer prognosis, and the development of more effective treatments.